20 participants
Efficacy, Safety and Tolerability of PF-06687234 as Add-on Therapy to Infliximab in Active UC Subjects Not in Remission.
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-12-28
- Start Date:
- 2017-12-20
- Completion:
- 2021-01-07
Conditions
- Ulcerative Colitis
Interventions
- DRUG